Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Trends Cancer. 2018 Sep 20;4(10):701–712. doi: 10.1016/j.trecan.2018.08.005

Figure 2. A snapshot of CT antigen behavior in tumors cells.

Figure 2.

In addition to their capacity to evoke an immune response through antigen presentation, CT antigens have been demonstrated to contribute to diverse neoplastic behaviors. CT antigens depicted here (in green) serve as key examples of how aberrant expression of these proteins can influence tumor cell regulatory networks. Abbreviations: MHC, major histocompatibility complex; TCR, T cell receptor; Ub, ubiquitin; RA, retinoic acid; PcG, polycomb group; TGFβ, transforming growth factor beta.